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Introduction
Bone is programmed to withstand low-energy trauma and
repeated stimuli such as walking, running, and jumping to an
extent. The ability of bone to withstand physiological stress is
governed by not only its determinants including mass,
geometry, and microarchitecture but also intrinsic bone tissue
quality. Intrinsic bone tissue quality is governed by the degree
of mineralization and matrix characteristics such as collagen
fiber orientation and chemical structure, both of which help to
characterize the bone ultrastructure, and while the exact roles
these determinants play are poorly understood, they appear to
be crucial for the overall understanding of bone mechanical
properties. These determinants are affected by bone remodel-
ing and may therefore be considered as targets of nutritional,
hormonal, and therapeutic intervention and activity. If we are
to understand how bone adapts to a loss of mass and responds
to pathophysiological alteration or to treatment, all such
affected contituents need to be considered systematically,
including intrinsic bone tissue quality.
Measurement of bone mechanical properties
Biomechanical tests of resistance to fracture provide an
objective measure of overall bone quality. They are invasive
and performed only in animal models but are of major
importance in the understanding of pathophysiological
alteration of bone strength. In the animal model,
biomechanical properties of both intact cortical and
trabecular bone are investigated by axial compression of
vertebral bodies and proximal tibiae. Purely cortical bone
is tested by flexion, whereby force is applied at either
three or four points. The load/deflection curve is then
used to measure or extrapolate stiffness (the slope of the
linear portion of the curve) and maximal load (load at
point of fracture). The departure from linearity represent-
ing the separation between elastic (linear) deformation
and plastic (nonlinear) deformation is defined as the yield
point. The areas under these curves represent the energies
absorbed during elastic and plastic deformation.
Measurement of intrinsic bone tissue quality
Various techniques are available for assessing and quanti-
fying intrinsic bone tissue quality at both the level of the
bone structural units (BSU) by microindentation and at
lamella level by nanoindentation. They both give an overall
reading of intrinsic quality as influenced by the mineral and
organic components, but only nanoindentation selectively
evaluates the influence of each. Microindentation is used to
measure microhardness at the BSU or tissue level in terms
of resistance to indentation at a defined load over a defined
time period. Nanoindentation measures hardness at the
level of the individual lamella. The nanoindentation method
involves fixing the loading and unloading rates in order to
obtain a force displacement curve, which can then be
employed to derive biomechanical parameters such as
microhardness and Young's elastic modulus. Microindenta-
tion uses a set load for a set time, with only the depth,
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imprint, and hence the diameter of the residual imprint varying
with the test material. The dimensions of this residual imprint
are used to calculate microhardness (kg/mm2), without the
ability to distinguish between the elastic and plastic
components. In the following discussion, results were
obtained using nanoindentation.
Relation between bone strength parameters
and parameters determined using nanoindentation
In the absence of treatment, ex vivo studies show an
excellent correlation between proximal femur bone mineral
density (BMD) and the maximal load obtained using
flexion tests of femoral neck and vertebral compression
tests. BMD predicts 66% to 74% of maximal load variance.
As a ratio between hydroxyapatite mineral content and scan
surface, BMD incorporates bone dimensions in addition to
mineral quantity. Indeed, the proficiency of BMD in
predicting bone strength is due, at least in part, to its
incorporation of bone size. In rats, vertebral BMD predicts
60% of the variance of maximal load. Including the
modulus (elastic tissue properties) improves the prediction
to 71.5% and hardness (plastic tissue properties) to 95%.
This indicates that combining BMD and tissue quality
allows for a reliable prediction of bone strength. There is a
significant relation between energy measured by compres-
sion testing of the rat vertebra and dissipated energy
measured at the tissue level by nanoindentation. This
demonstrates that the determination of energy is dominated
by the tissue quality, characterizing its plasticity. In
contrast, there is no relation between stiffness measured
by compression testing of the rat vertebra and modulus
measured at the tissue level by nanoindentation. This
demonstrates that the determination of stiffness is dominat-
ed by the geometry of the bone rather than by tissue quality.
These different studies clearly demonstrate the crucial role
of intrinsic bone tissue quality in the determination of bone
strength alongside geometry and microarchitecture.
The alteration of bone strength and the respective role
of intrinsic bone tissue quality
Bone is a heterogeneous tissue made up of a mineral
component (hydroxyapatite) and an organic (mostly collag-
enous) component. Each component is theoretically capable
of influencing the intrinsic quality of bone tissue. The
degree of mineralization remains the more studied aspect of
bone tissue to date. Studies of the organic component have
focused on collagen fiber orientation and maturity. The
involvement of these parameters in tissue quality is
especially evident in osteogenesis imperfecta where fiber
disorganization leads to the high fracture risk. Diseases
resulting in the formation of woven bone (disorganization
of the collagen matrix), such as Paget's, are also associated
with decreased strength. Preliminary studies are revealing
the importance of the intrinsic bone tissue quality. They
have shown tissue to be heterogeneous throughout the
different phases of bone remodeling. They also have found
evidence of changes in response to protein intake, hormone
impregnation, and osteoporosis treatments.
Intrinsic bone tissue quality: effect of estrogen deficiency
At the level of the femoral neck, ovariectomy resulted in an
early decrease of the mechanical properties, followed by a
recovery. The initial decrease was explained by a decreased
bone mass, an alteration of microarchitecture and of
intrinsic bone tissue quality. This was followed by a
compensatory increase of the external diameter of the
femoral neck, which alone explains the recovery of
maximal load in ovariectomized rats. This effect on
geometry is related to an increase in circulating IGF-I
observed following ovariectomy. These observations high-
light the importance of the geometry as a derminant of bone
strength.
Intrinsic bone tissue quality: effect of protein intake
An isocaloric reduction of protein intake in rats impairs
both cortical and trabecular intrinsic bone tissue quality
without necessarily needing remodeling of the bone tissue
involved. A recovery of material quality was also observed
following protein supplementation in rats fed a low casein
diet. A Fourier transform infrared imaging analysis shows
an increased maturation of bone collagen cross-links as
indicated by an improvement of Pyr/deH-DHLNL collagen
cross-link ratio in rats given protein supplements. This was
observed in areas of the bone not subject to bone
remodeling. Altogether, the supplementation of protein
restores bone mechanical properties by preventing further
BMD losses, increasing cortical thickness, and restoring
intrinsic bone tissue quality. Thus, protein intake can
directly influence the bone matrix quality and be crucial
for the determination of overall bone mechanical properties.
Intrinsic bone tissue quality: effects of osteoporosis
treatments
In OVX rats, bone mechanical properties are improved by
bisphosphonates, selective estrogen receptor modulator
(SERM), and parathyroid hormone (PTH) treament. Inhib-
itors of bone resorption prevent bone loss and the
degradation of microarchitecture; in contrast, PTH increases
bone mass. Intrinsic bone tissue quality was improved
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following treatments with inhibitors of bone resorption:
SERM>bisphosphonates, but not in PTH-treated rats. This
positive effect was in relation to the level of mineralization
achieved in bisphosphonate-treated rats, while in SERM-
treated rats the origin of the improvement is yet to be
elucidated. This underlines the selective effect of osteopo-
rosis treatments on the different determinants of bone
strength. Other works have shown the response of intrinsic
bone tissue quality to strontium ranelate treatment, with
significant increases in both elastic and plastic parameters
to even higher values than those observed in sham controls.
Strontium ranelate treatment improves trabecular and
cortical intrinsic bone tissue quality. This novel property,
namely, the improvement of the intrinsic quality of bone
tissue that is newly formed in response to strontium
ranelate, may lead to a decrease in the development and/
or propagation of microcracks. Such an effect on intrinsic
bone tissue quality may signify a new target for developers
of treatments for osteoporosis.
Conclusion
The direct measurement of bone strength provides an
objective measurement of bone quality and integrates all
the effects of the different determinants. Mechanical
property determinants, such as geometry, microarchitecture,
and intrinsic bone tissue quality, are influenced selectively
by the different available treatments and nutritional and
hormonal status. A recent study clearly indicated that
intrinsic bone tissue quality plays a major role. It is altered
by estrogen deficiency and low protein intake and partially
restored by protein renutrition, bisphosphonates, and
SERMs but not by PTH. The most effective treatment,
however, was strontium ranelate which increased intrinsic
bone tissue quality significantly, even compared to the
control animals. This highlights the prominent role played
by intrinsic bone tissue quality in determining bone
strength, which may thus become a new target for
developers of anti-osteoporotic therapies.
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